Abstract

Introduction: While new therapies have improved the prognosis of patients post acute myocardial infarction, many patients still suffer from irreversible damage and live with the debilitating consequences. However, with the advent of stem cell-based therapies, future treatments may enable us to harness the potential of autologous stem cells to prevent and even reverse heart damage.Areas covered: We outline the results of the early clinical trials using autologous cell therapy and highlight the hurdles and limitations that still need to be addressed. We also discuss new approaches that hold promise for developing the next generations of autologous cell therapy by exploring strategies to enhance their regenerative activity using biomaterials, genetic modification, optimal cell types and small molecule preconditioning.Expert opinion: Autologous cell therapy may be on the cusp of being widely adopted for the treatment of patients with large areas of myocardial damage. Techniques to enhance the activity and retention of autologous cell products may represent the next generation of this therapy.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.